FSTL3 is often associated with the progression of malignant tumors by inducing the epithelial-mesenchymal transition (EMT), affecting the tumor microenvironment, influencing non-coding RNA regulation, and promoting angiogenesis. This evidence concerns the gene FSTL3 and neoplasm.